COPD guidelines: a review of the 2018 GOLD report

S Mirza, RD Clay, MA Koslow, PD Scanlon - Mayo Clinic Proceedings, 2018 - Elsevier
Abstract Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018 is a
consensus report published periodically since 2001 by an international panel of health …

Personalized medicine for patients with COPD: where are we?

FME Franssen, P Alter, N Bar… - … journal of chronic …, 2019 - Taylor & Francis
Chronic airflow limitation is the common denominator of patients with chronic obstructive
pulmonary disease (COPD). However, it is not possible to predict morbidity and mortality of …

Role of type2 inflammatory biomarkers in chronic obstructive pulmonary disease

K Oishi, K Matsunaga, T Shirai, K Hirai… - Journal of Clinical …, 2020 - mdpi.com
Airway inflammation in chronic obstructive pulmonary disease (COPD) is typically thought to
be driven by Type1 immune responses, while Type2 inflammation appears to be present in …

Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions

E Azoulay, V Lemiale, B Mourvillier… - Intensive Care …, 2018 - Springer
Rationale The standard of care for patients with acute respiratory distress syndrome (ARDS)
has been developed based on studies that usually excluded patients with major …

Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry

S Kobayashi, M Hanagama, M Ishida… - … journal of chronic …, 2018 - Taylor & Francis
Purpose The GOLD report provides a framework for classifying COPD in a way that reflects
its clinical impact and allows treatment recommendations. The GOLD 2017 proposes a new …

COPD patients' characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study

I Tsiligianni, M Kampouraki… - … Journal of Chronic …, 2019 - Taylor & Francis
Purpose GOLD guidelines classify COPD patients into A–D groups based on health status
as assessed by COPD Assessment Test (CAT) or mMRC tools and exacerbations and …

What is the impact of GOLD 2017 recommendations in primary care?–a descriptive study of patient classifications, treatment burden and costs

A Gayle, S Dickinson, K Morris, C Poole… - … journal of chronic …, 2018 - Taylor & Francis
Purpose The changes in grading of disease severity and treatment recommendations for
patients with COPD in the 2017 GOLD strategy may present an opportunity for reducing …

Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort

LAK Le, A Johannessen, JA Hardie… - … journal of chronic …, 2019 - Taylor & Francis
Rationale The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 is based
on an ABCD assessment tool of symptoms and exacerbation history and grade 1–4 of …

Clinical–functional characteristics and risk of exacerbation and mortality among more symptomatic patients with chronic obstructive pulmonary disease: a retrospective …

Q Song, L Lin, W Cheng, XS Li, YQ Zeng, C Liu… - BMJ open, 2023 - bmjopen.bmj.com
Objectives The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017
classified chronic obstructive pulmonary disease (COPD) patients into more and less …

The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of …

MJ Hsieh, SY Huang, TM Yang, CW Tao… - … journal of chronic …, 2018 - Taylor & Francis
Background This nationwide study was performed to evaluate the evolution of distributions
of patients with COPD according to the 2011 and 2017 Global Initiative for Chronic …